Get started
Author

Takashi Yokokawa

Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis
2023 · Takuji Okusaka, Masafumi Nakamura, et al. · International Journal of Clinical Oncology · 182
PDF
Patients’ self-reported adherence to capecitabine on XELOX treatment in metastatic colorectal cancer: findings from a retrospective cohort analysis
2015 · Kazuyoshi Kawakami, Takashi Yokokawa, et al. · Patient Preference and Adherence · 29
PDF
Association of Immune-Related Adverse Events with Pembrolizumab Efficacy in the Treatment of Advanced Urothelial Carcinoma
2020 · Kazuo Kobayashi, Kenichi Suzuki, et al. · Oncology · 27
Association of Hand-Foot Skin Reaction with Regorafenib Efficacy in the Treatment of Metastatic Colorectal Cancer
2019 · Kazuo Kobayashi, Kazuyoshi Kawakami, et al. · Oncology · 26
Association Between Immune-related Adverse Events and Clinical Outcome Following Nivolumab Treatment in Patients With Metastatic Renal Cell Carcinoma
2020 · KAZUO KOBAYASHI, YUSUKE IIKURA, et al. · In Vivo · 20
PDF
Usefulness of Pharmaceutical Outpatient Clinic in XELOX Therapy
2011 · Yutaro Mae, Takashi Yokokawa, et al. · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) · 19
PDF
Self-Reported Adherence to Capecitabine on XELOX Treatment as Adjuvant Therapy for Colorectal Cancer
2017 · Kazuyoshi Kawakami, Takashi Yokokawa, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 18
Self-Reported Adherence to Trifluridine and Tipiracil Hydrochloride for Metastatic Colorectal Cancer: A Retrospective Cohort Study
2016 · Kazuo Sugita, Kazuyoshi Kawakami, et al. · Oncology · 17
Associations among plasma concentrations of regorafenib and its metabolites, adverse events, and ABCG2 polymorphisms in patients with metastatic colorectal cancers
2021 · Kazuo Kobayashi, Erika Sugiyama, et al. · Cancer Chemotherapy and Pharmacology · 15
Factors Associated With Regorafenib Adherence With Metastatic Colorectal Cancer
2019 · Kazuyoshi Kawakami, Takeru Wakatsuki, et al. · Patient Preference and Adherence · 14
PDF
Risk Factors Exacerbating Hand-Foot Skin Reaction Induced by Capecitabine plus Oxaliplatin with or without Bevacizumab Therapy
2015 · Takashi Yokokawa, Kazuyoshi Kawakami, et al. · Annals of Pharmacotherapy · 14
Investigation of Regorafenib-induced Hypothyroidism in Patients with Metastatic Colorectal Cancer.
2015 · Kazuo Sugita, Kazuyoshi Kawakami, et al. · PubMed · 13
A Feasibility Study of Capecitabine and Oxaliplatin for Patients with Stage Ⅱ/Ⅲ Colon Cancer –ACTOR Study–
2018 · MITSUKUNI SUENAGA, TAKASHI AKIYOSHI, et al. · Anticancer Research · 11
PDF
Environmental Contamination due to Preparation of Cyclophosphamide and Exposure of Pharmacists to It
2009 · Toshihiro Hama, Takeshi Aoyama, et al. · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) · 10
PDF
Regorafenib-Induced Hand‐Foot Skin Reaction Is More Severe on the Feet Than on the Hands
2018 · Yuma Nonomiya, Takashi Yokokawa, et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 9
Influence of menopause on chemotherapy‐induced nausea and vomiting in highly emetogenic chemotherapy for breast cancer: A retrospective observational study
2023 · Takashi Yokokawa, Kenichi Suzuki, et al. · Cancer Medicine · 8
PDF
The Combined Use of 5 or More Drugs Is a Factor Related to Lower Adherence to S-1 in S-1 and Oxaliplatin Treatment for Advanced Gastric Cancer
2021 · Kazuyoshi Kawakami, Takeshi Aoyama, et al. · Biological and Pharmaceutical Bulletin · 8
PDF
Risk factors for severe neutropenia in pancreatic cancer patients treated with gemcitabine/nab-paclitaxel combination therapy
2021 · Genta Ito, Kazuyoshi Kawakami, et al. · PLoS ONE · 8
PDF
Fast and Ultrasensitive Glycoform Analysis by Supercritical Fluid Chromatography–Tandem Mass Spectrometry
2022 · Yoshimi Haga, Masaki Yamada, et al. · Analytical Chemistry · 7
PDF
Pharmacogenomic study of gemcitabine efficacy in patients with metastatic pancreatic cancer: A multicenter, prospective, observational cohort study (GENESECT study)
2024 · Masahiro Hatori, Daiki Tsuji, et al. · Cancer · 6
PDF
Impact of Primary Pegfilgrastim Prophylaxis on Relative Dose Intensity in Neoadjuvant/Adjuvant FEC-100 Chemotherapy
2020 · TAKASHI YOKOKAWA, KENICHI SUZUKI, et al. · Anticancer Research · 6
PDF
Serum Creatinine Elevation as a Risk Factor for Niraparib-induced Hematologic Toxicity
2023 · KOKI HASHIMOTO, KAZUYOSHI KAWAKAMI, et al. · Anticancer Research · 4
PDF
Correlation between magnesium pre-loading and cisplatin-induced nephrotoxicity in 5-fluorouracil/cisplatin combination therapy for esophageal cancer
2022 · T. Sugisaki, T. Aoyama, et al. · Die Pharmazie · 4
PDF
Factors associated with lenvatinib adherence in thyroid cancer and hepatocellular carcinoma
2023 · Yoshikazu Tateai, Kazuyoshi Kawakami, et al. · PLoS ONE · 3
PDF
Factors Affecting Delayed Recovery from Neutropenia in Patients with pancreatic Cancer Receiving Gemcitabine Plus Nab-Paclitaxel
2025 · Naoko Yoshida, Shungo Imai, et al. · Journal of Cancer · 2
PDF
Works count: 61
Citation count: 494
H-index: 12
I10-index: 14
Year
Topic
Type